» Articles » PMID: 38110537

The Impact of a Fracture Liaison Service After 3 years on Secondary Fracture Prevention and Mortality in a Portuguese Tertiary Center

Overview
Journal Arch Osteoporos
Publisher Springer
Date 2023 Dec 19
PMID 38110537
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Fracture Liaison Services (FLS) have been established worldwide, with positive effects on treatment, secondary fracture, mortality, and economic burden. However, no study has evaluated their impact on the Portuguese population. Therefore, we purposed to evaluate the effect of an FLS model in a Portuguese center on osteoporosis (OP) treatment, secondary fracture, and mortality rates, 3 years after a fragility fracture.

Methods: Patients over 50 years old, admitted with a fragility fracture, between January 2017 and December 2020, were included in this retrospective study. Patients evaluated after FLS implementation (2019-2020) were compared with those evaluated before (2017-2018) and followed for 36 months. Predictors of secondary fracture and mortality were assessed using a multivariate Cox regression model, adjusted to potential confounders.

Results: A total of 551 patients were included (346 before and 205 after FLS). The FLS significantly increased the rate of OP treatment, when compared with standard clinical practice (8.1% vs 77.6%). During follow-up, the secondary fracture rate was 14.7% and 7.3%, before and after FLS, respectively. FLS was associated with a lower risk of secondary fracture (HR 0.39, C.I. 0.16-0.92). Although we observed a lower mortality rate (25.1% vs 13.7%), FLS was not a significant predictor of survival.

Conclusion: Implementing the FLS model in a Portuguese center has increased OP treatment and reduced the risk of secondary fracture. We believe that our work supports adopting FLS models in national programs.

References
1.
Pisani P, Renna M, Conversano F, Casciaro E, Di Paola M, Quarta E . Major osteoporotic fragility fractures: Risk factor updates and societal impact. World J Orthop. 2016; 7(3):171-81. PMC: 4794536. DOI: 10.5312/wjo.v7.i3.171. View

2.
Branco J, Rodrigues A, Gouveia N, Eusebio M, Ramiro S, Machado P . Prevalence of rheumatic and musculoskeletal diseases and their impact on health-related quality of life, physical function and mental health in Portugal: results from EpiReumaPt- a national health survey. RMD Open. 2016; 2(1):e000166. PMC: 4731842. DOI: 10.1136/rmdopen-2015-000166. View

3.
Kanis J, Norton N, Harvey N, Jacobson T, Johansson H, Lorentzon M . SCOPE 2021: a new scorecard for osteoporosis in Europe. Arch Osteoporos. 2021; 16(1):82. PMC: 8172408. DOI: 10.1007/s11657-020-00871-9. View

4.
Barcelos A, Goncalves J, Mateus C, Canhao H, Rodrigues A . Costs of incident non-hip osteoporosis-related fractures in postmenopausal women from a payer perspective. Osteoporos Int. 2023; 34(12):2111-2119. PMC: 10651527. DOI: 10.1007/s00198-023-06881-w. View

5.
Barcelos A, Goncalves J, Mateus C, Canhao H, Rodrigues A . Costs of Hip Fractures in Postmenopausal Women in Portugal: A Study from the Payer's Perspective. Acta Med Port. 2023; 36(12):848-849. DOI: 10.20344/amp.20481. View